In this study, we reveal that the PRMT6-YTHDF2-Wnt-β-Catenin axis promotes migration, invasion, and EMT in gliomas, both in vivo and in vitro (Fig. 9E). This evidence concerns the gene PRMT6 and central nervous system cancer.